Urabe F - Search Results

1

Recent advances in basic research on prostate cancer: Where we are heading?

Obinata D, Yamada Y, Sumiyoshi T, Tanegashima T, Watanabe R, Kobayashi H, Ito D, Urabe F; Japanese Young Urologist Basic Research Collaboration. Obinata D, et al. Among authors: urabe f. Int J Urol. 2024 Oct 30. doi: 10.1111/iju.15628. Online ahead of print. Int J Urol. 2024. PMID: 39474871 Review.

2

Estimated glomerular filtration rate on postoperative day 1 is associated with renal functional outcome after percutaneous renal cryoablation for renal tumors.

Urabe F, Kimura T, Miki J, Shimizu K, Kishimoto K, Egawa S. Urabe F, et al. Int J Urol. 2017 Jul;24(7):553-554. doi: 10.1111/iju.13361. Epub 2017 May 14. Int J Urol. 2017. PMID: 28503794 No abstract available.

3

Extracellular vesicles: Toward a clinical application in urological cancer treatment.

Urabe F, Kosaka N, Kimura T, Egawa S, Ochiya T. Urabe F, et al. Int J Urol. 2018 Jun;25(6):533-543. doi: 10.1111/iju.13594. Epub 2018 May 3. Int J Urol. 2018. PMID: 29726046 Review.

4

Salvage surgery for residual disease following unsuccessful laparoscopic radical prostatectomy for prostate cancer.

Tashiro K, Urabe F, Ito D, Atsuta M, Sasaki H, Egawa S. Tashiro K, et al. Among authors: urabe f. Urol Case Rep. 2020 Oct 1;34:101435. doi: 10.1016/j.eucr.2020.101435. eCollection 2021 Jan. Urol Case Rep. 2020. PMID: 33083234 Free PMC article.

5

Supine extraperitoneal laparoscopic nephroureterectomy without patient repositioning.

Miki J, Yanagisawa T, Iwatani K, Obayashi K, Fukuokaya W, Mori K, Urabe F, Tsuzuki S, Kimura S, Kimura T, Egawa S. Miki J, et al. Among authors: urabe f. Int J Urol. 2021 Feb;28(2):163-168. doi: 10.1111/iju.14415. Epub 2020 Nov 16. Int J Urol. 2021. PMID: 33197988

6

Editorial Comment from Dr Urabe to Diagnostic performance of prostate cancer antigen 3 and the Prostate Health Index in detecting overall and clinically significant prostate cancer in men at first biopsy: A meta-analysis.

Urabe F. Urabe F. Int J Urol. 2021 Mar;28(3):325-326. doi: 10.1111/iju.14467. Epub 2020 Dec 19. Int J Urol. 2021. PMID: 33341976 No abstract available.

7

Editorial Comment from Dr Urabe to Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.

Urabe F. Urabe F. Int J Urol. 2021 Jul;28(7):776. doi: 10.1111/iju.14580. Epub 2021 Apr 21. Int J Urol. 2021. PMID: 33884688 No abstract available.

8

Serum microRNA as liquid biopsy biomarker for the prediction of oncological outcomes in patients with bladder cancer.

Urabe F, Matsuzaki J, Ito K, Takamori H, Tsuzuki S, Miki J, Kimura T, Egawa S, Nakamura E, Matsui Y, Fujimoto H, Yamamoto Y, Ochiya T. Urabe F, et al. Int J Urol. 2022 Sep;29(9):968-976. doi: 10.1111/iju.14858. Epub 2022 Mar 14. Int J Urol. 2022. PMID: 35288995

9

Editorial Comment from Dr. Urabe to Impact of family history on clinicopathological variables and disease progression in Japanese prostate cancer patients undergoing robotic-assisted radical prostatectomy.

Urabe F. Urabe F. Int J Urol. 2022 Nov;29(11):1346-1347. doi: 10.1111/iju.15011. Epub 2022 Aug 24. Int J Urol. 2022. PMID: 36001300 No abstract available.

10

miRNAs in prostate cancer: Intercellular and extracellular communications.

Urabe F, Yamamoto Y, Kimura T. Urabe F, et al. Int J Urol. 2022 Dec;29(12):1429-1438. doi: 10.1111/iju.15043. Epub 2022 Sep 19. Int J Urol. 2022. PMID: 36122303 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters